$2.80
0.01[0.36%]
Last update: 8:35AM Get Real Time Here
Anebulo Pharmaceuticals
(NASDAQ:ANEB)Latest News for Anebulo Pharmaceuticals Stock (NASDAQ:ANEB)
Anebulo Pharmaceuticals Stock (NASDAQ: ANEB)
Categories: All
Wednesday, February 14, 2024
Tuesday, February 13, 2024
Thursday, January 11, 2024
Thursday, December 21, 2023
Tuesday, November 14, 2023
Tuesday, October 17, 2023
Thursday, October 12, 2023
Wednesday, October 11, 2023
Friday, October 06, 2023
Tuesday, October 03, 2023
Monday, September 25, 2023
Thursday, September 21, 2023
Wednesday, September 20, 2023
Monday, September 18, 2023
- Substance Use Disorder Focused Anebulo Could Be Attractive Acquisition Target, Analyst SaysVandana Singh - Sep 18, 2023, 1:13PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023Benzinga Insights - Sep 18, 2023, 11:00AM
- HC Wainwright & Co. Initiates Coverage On Anebulo Pharmaceuticals with Buy Rating, Announces Price Target of $6Benzinga Newsdesk - Sep 18, 2023, 6:33AM
Tuesday, September 05, 2023
Tuesday, August 22, 2023
Monday, August 21, 2023
- Anebulo Receives Positive Feedback From FDA On Path To Phase 3 Trial Of Its Drug For Acute Cannabinoid IntoxicationVuk Zdinjak - Aug 21, 2023, 9:23AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Aug 21, 2023, 9:06AM
- Anebulo Receives Positive Feedback From FDA On Path To Advance Phase 3 Clinical Development Of ANEB-001 And Completes Dosing Of Phase 2 ExtensionBenzinga Newsdesk - Aug 21, 2023, 8:04AM
Thursday, May 18, 2023
Thursday, May 11, 2023
Wednesday, March 29, 2023
Tuesday, March 28, 2023
Monday, March 13, 2023
Wednesday, March 08, 2023
Tuesday, March 07, 2023
Tuesday, February 14, 2023
Friday, February 10, 2023
Monday, January 30, 2023
Monday, January 09, 2023
- Acute Cannabinoid Intoxication: This Pharma Company's Clinical Trials To Reduce And Treat SymptomsJoana Scopel - Jan 9, 2023, 2:46PM
- Anebulo Pharmaceuticals Announced Completion of Dosing and Preliminary Data from Part B of its Phase 2 Study of ANEB-001 for Acute Cannabinoid IntoxicationCharles Gross - Jan 9, 2023, 8:04AM
Monday, December 19, 2022
Tuesday, December 06, 2022
Thursday, November 10, 2022
Wednesday, November 02, 2022
Tuesday, October 25, 2022
Wednesday, October 19, 2022
Tuesday, October 18, 2022
Tuesday, October 04, 2022
Monday, October 03, 2022
Monday, September 26, 2022
- Lower Doses Of Anebulo's ANEB-001 Reduces Negative Effects Of Higher Doses Of THCVandana Singh - Sep 26, 2022, 8:56AM
- Anebulo Pharmaceuticals Announces Interim Data For ANEB-001 From Part B Of Its Phase 2 Clinical Trial For Acute Cannabinoid Intoxication; Says Lower Doses Of ANEB-001 Reduced The Negative Effects Of Higher Doses Of THCBill Haddad - Sep 26, 2022, 7:04AM